Meine Zukunft Innovative Chemie Interviews Inspirierende Job-Links Meine Ausbildung

Intercell AG

Firmenlogo

Intercell is a biopharmaceutical, science-driven company with an integrated system for the development of molecularly defined prophylactic and therapeutic vaccines against infectious diseases and certain forms of cancer. This new generation of vaccines, the so-called "smart vaccines", are now being developed by Intercell, a highly innovative, efficient and quality-orientated company with around 100 employees from 14 different countries.

News Focussing on Members

(AVIR Green Hills Biotechnology AG) deltaFLU –innovative vaccines for intranasal spray delivery or oral administration more 

 

(Apeptico) APEPTICO Announces Successful Completion of Phase I Trial with AP301 in Oedematous Respiratory Failure  more 

 

(Intercell) Intercell announces new management structure more 

 

(Eucodis) EUCODIS Bioscience and evocatal enter into alliance more 

 

(Intercell) Staph Bakali new Chief Business Officer more 

 

(Intercell) Intercell acquires antibody technology platform to further exploit its capabilities to combat infectious diseases more 

 

(Apeptico) APEPTICO granted Orphan Drug Designation by FDA for development compound AP301 more